EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Interferon regulation in cancer: tumor vulnerabilities, oncolytic virus exploitation, and emerging immunotherapeutic strategies

Ali M Atoom, Jasur Rizaev, Djamila Polatova, Pareshkumar N Patel, K V Jamuna, Laxmidhar Maharana, Neeraj Bainsal, Divya Singhal

Cancer Treatment and Research Communications · 2026 · 49 · 101511

DOI: 10.1016/j.ctarc.2026.101511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Ali M Atoom und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: a…. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) are central regulators of antitumor immunity, cellular stress responses, and host defense mechanisms, yet their functions in cancer are highly context dependent. This review examines the dual role of IFN signaling in cancer, highlighting how tumors exploit defects in IFN pathways to escape immune surveillance while also exposing therapeutic vulnerabilities that can be targeted for treatment. Alterations in IFN production, signaling networks, and downstream effector mechanisms influence tumor initiation, progression, immune evasion, and therapeutic resistance. We discuss the molecular mechanisms by which cancer cells reshape IFN responses, including disruptions in antigen presentation, immune recognition, and tumor microenvironment interactions. Furthermore, oncolytic viruses exploit tumor-specific defects in antiviral signaling pathways, particularly IFN-related vulnerabilities, to selectively infect and eliminate malignant cells while stimulating antitumor immunity. Recent advances in immunotherapeutic strategies, including immune checkpoint blockade, adoptive cell therapies, and combination approaches integrating IFN modulation with viral-based therapies, have expanded opportunities for exploiting IFN biology in precision oncology. This review summarizes current mechanistic insights, therapeutic strategies, and emerging challenges associated with targeting IFN regulation in cancer. By integrating molecular mechanisms with translational applications, we provide a comprehensive framework for understanding how IFN pathways can be manipulated to improve cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

Cancer immunityImmunotherapyInterferon signalingOncolytic virusesTumor vulnerabilities

Autor:innen und Institutionen

  • Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: a.atoom@ammanu.edu.jo.
  • Department of Public Health and Healthcare management, Rector, Samarkand State Medical University, Samarkand, Uzbekistan. Electronic address: rizaevjasur@yahoo.com.
  • Scientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, Uzbekistan. Electronic address: botir.elov@mail.ru.
  • Department of Pharmacy, Faculty of Pharmacy, Gokul Global University, Sidhpur, Gujarat, India. Electronic address: dean.fac.pharmacy@gokuluniversity.ac.in.
  • Department of Forensic Science, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India. Electronic address: kv.jamuna@jainuniversity.ac.in.
  • Department of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751030, India. Electronic address: laxmidharmaharana@soa.ac.in.

Zitieren

APA

Atoom, A. M., Rizaev, J., Polatova, D., Patel, P. N., Jamuna, K. V., Maharana, L., Bainsal, N., & Singhal, D. (2026). Interferon regulation in cancer: tumor vulnerabilities, oncolytic virus exploitation, and emerging immunotherapeutic strategies. Cancer Treatment and Research Communications, 49, 101511. https://doi.org/10.1016/j.ctarc.2026.101511

Vancouver

Atoom AM, Rizaev J, Polatova D, Patel PN, Jamuna KV, Maharana L, et al. Interferon regulation in cancer: tumor vulnerabilities, oncolytic virus exploitation, and emerging immunotherapeutic strategies. Cancer Treatment and Research Communications. 2026;49:101511. doi:10.1016/j.ctarc.2026.101511

BibTeX
@article{Atoom2026,
  author = {Atoom, Ali M and Rizaev, Jasur and Polatova, Djamila and Patel, Pareshkumar N and Jamuna, K V and Maharana, Laxmidhar and Bainsal, Neeraj and Singhal, Divya},
  title = {Interferon regulation in cancer: tumor vulnerabilities, oncolytic virus exploitation, and emerging immunotherapeutic strategies},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101511},
  doi = {10.1016/j.ctarc.2026.101511}
}
Kostenlos starten →